BIOMARIN PHARMACEUTICAL INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 791.70 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-02-26
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-03-31 was 1.58M shares, a 105.87% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2018-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2018-09-30 was 6.86K shares, a 86.80% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 791.70K shares, a 8.99% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 726.43K shares, a 3.10% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 704.59K shares, a 1.35% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 695.18K shares, a 4.44% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2025-12-31 | 791.70K shares 10-K · filed 2026-02-26 | |||
| 2024-12-31 | 726.43K shares 10-K · filed 2025-02-24 | |||
| 2023-12-31 | 704.59K shares 10-K · filed 2024-02-26 | |||
| 2022-12-31 | 695.18K shares 10-K · filed 2023-02-27 | |||
| 2021-12-31 | 665.61K shares 10-K · filed 2022-02-25 | |||
| 2020-12-31 | 891.61K shares 10-K · filed 2021-02-26 | |||
| 2019-12-31 | 610.25K shares 10-K · filed 2020-02-27 | |||
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | 1.58M shares 10-Q · filed 2019-08-02 | 1.58M shares derived: sum of 3 quarters · filed 2019-08-02 | 1.59M shares derived: sum of 4 quarters · filed 2019-08-02 |
| 2019-03-31 | 1.58M shares 10-Q · filed 2019-04-29 | 1.58M shares derived: sum of 2 quarters · filed 2019-04-29 | 1.59M shares derived: sum of 3 quarters · filed 2019-04-29 | 1.59M shares derived: sum of 4 quarters · filed 2019-04-29 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | 6.86K shares derived: sum of 2 quarters · filed 2019-02-28 | 15.43K shares derived: sum of 3 quarters · filed 2019-02-28 | 782.24K shares 10-K · filed 2019-02-28 |
| 2018-09-30 | 6.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | 15.43K shares derived: sum of 2 quarters · filed 2018-10-26 | 782.24K shares 10-Q · filed 2018-10-26 | 798.11K shares derived: sum of 4 quarters · filed 2018-10-26 |
| 2018-06-30 | 8.57K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | 775.38K shares 10-Q · filed 2018-08-03 | 791.25K shares derived: sum of 3 quarters · filed 2018-08-03 | 843.22K shares derived: sum of 4 quarters · filed 2018-08-03 |
| 2018-03-31 | 766.81K shares 10-Q · filed 2018-04-27 | 782.68K shares derived: sum of 2 quarters · filed 2018-04-27 | 834.65K shares derived: sum of 3 quarters · filed 2018-04-27 | 882.11K shares derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-12-31 | 15.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | 67.84K shares derived: sum of 2 quarters · filed 2018-02-26 | 115.30K shares derived: sum of 3 quarters · filed 2018-02-26 | 801.17K shares 10-K · filed 2018-02-26 |
| 2017-09-30 | 51.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | 99.43K shares derived: sum of 2 quarters · filed 2017-10-31 | 785.30K shares 10-Q · filed 2017-10-31 | 849.17K shares derived: sum of 4 quarters · filed 2017-10-31 |
| 2017-06-30 | 47.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 733.33K shares 10-Q · filed 2017-08-02 | 797.20K shares derived: sum of 3 quarters · filed 2017-08-02 | 820.77K shares derived: sum of 4 quarters · filed 2017-08-02 |
| 2017-03-31 | 685.87K shares 10-Q · filed 2017-05-04 | 749.74K shares derived: sum of 2 quarters · filed 2017-05-04 | 773.31K shares derived: sum of 3 quarters · filed 2017-05-04 | 817.78K shares derived: sum of 4 quarters · filed 2017-05-04 |
| 2016-12-31 | 63.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | 87.44K shares derived: sum of 2 quarters · filed 2017-02-27 | 131.91K shares derived: sum of 3 quarters · filed 2017-02-27 | 847.45K shares 10-K · filed 2017-02-27 |
| 2016-09-30 | 23.57K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 68.04K shares derived: sum of 2 quarters · filed 2016-11-03 | 783.58K shares 10-Q · filed 2016-11-03 | 793.68K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 44.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | 760.01K shares 10-Q · filed 2016-08-08 | 770.11K shares derived: sum of 3 quarters · filed 2016-08-08 | 800.51K shares derived: sum of 4 quarters · filed 2016-08-08 |
| 2016-03-31 | 715.54K shares 10-Q · filed 2016-05-02 | 725.64K shares derived: sum of 2 quarters · filed 2016-05-02 | 756.04K shares derived: sum of 3 quarters · filed 2016-05-02 | 802.24K shares derived: sum of 4 quarters · filed 2016-05-02 |
| 2015-12-31 | 10.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 40.50K shares derived: sum of 2 quarters · filed 2016-02-29 | 86.70K shares derived: sum of 3 quarters · filed 2016-02-29 | 728.77K shares 10-K · filed 2016-02-29 |
| 2015-09-30 | 30.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | 76.60K shares derived: sum of 2 quarters · filed 2015-11-02 | 718.67K shares 10-Q · filed 2015-11-02 | 726.67K shares derived: sum of 4 quarters · filed 2015-11-02 |
| 2015-06-30 | 46.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | 688.27K shares 10-Q · filed 2015-08-05 | 696.27K shares derived: sum of 3 quarters · filed 2015-08-05 | 751.17K shares derived: sum of 4 quarters · filed 2015-08-05 |
| 2015-03-31 | 642.07K shares 10-Q · filed 2015-05-05 | 650.07K shares derived: sum of 2 quarters · filed 2015-05-05 | 704.97K shares derived: sum of 3 quarters · filed 2015-05-05 | 1.72M shares derived: sum of 4 quarters · filed 2015-05-05 |
| 2014-12-31 | 8.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 62.90K shares derived: sum of 2 quarters · filed 2015-03-02 | 1.08M shares derived: sum of 3 quarters · filed 2015-03-02 | 1.19M shares 10-K · filed 2015-03-02 |
| 2014-09-30 | 54.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | 1.07M shares derived: sum of 2 quarters · filed 2014-10-28 | 1.18M shares 10-Q · filed 2014-10-28 | 1.33M shares derived: sum of 4 quarters · filed 2014-10-28 |
| 2014-06-30 | 1.01M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | 1.12M shares 10-Q · filed 2014-07-31 | 1.27M shares derived: sum of 3 quarters · filed 2014-07-31 | 3.68M shares derived: sum of 4 quarters · filed 2014-07-31 |
| 2014-03-31 | 107.92K shares 10-Q · filed 2014-05-02 | 259.32K shares derived: sum of 2 quarters · filed 2014-05-02 | 2.66M shares derived: sum of 3 quarters · filed 2014-05-02 | 2.46M shares derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-12-31 | 151.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | 2.56M shares derived: sum of 2 quarters · filed 2014-02-26 | 2.35M shares derived: sum of 3 quarters · filed 2014-02-26 | 2.56M shares 10-K · filed 2014-02-26 |
| 2013-09-30 | 2.40M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | 2.20M shares derived: sum of 2 quarters · filed 2013-10-28 | 2.40M shares 10-Q · filed 2013-10-28 | 2.50M shares derived: sum of 4 quarters · filed 2013-10-28 |
| 2013-06-30 | -200.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | 2.20 shares 10-Q · filed 2013-07-29 | 96.57K shares derived: sum of 3 quarters · filed 2013-07-29 | 196.57K shares derived: sum of 4 quarters · filed 2013-07-29 |
| 2013-03-31 | 200.55K shares 10-Q · filed 2013-04-29 | 297.12K shares derived: sum of 2 quarters · filed 2013-04-29 | 397.12K shares derived: sum of 3 quarters · filed 2013-04-29 | 2.30M shares derived: sum of 4 quarters · filed 2013-04-29 |
| 2012-12-31 | 96.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | 196.57K shares derived: sum of 2 quarters · filed 2013-02-26 | 2.10M shares derived: sum of 3 quarters · filed 2013-02-26 | 2.30M shares 10-K · filed 2013-02-26 |
| 2012-09-30 | 100.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | 2.00M shares derived: sum of 2 quarters · filed 2012-10-29 | 2.20M shares 10-Q · filed 2012-10-29 | 2.47M shares derived: sum of 4 quarters · filed 2013-02-26 |
| 2012-06-30 | 1.90M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | 2.10M shares 10-Q · filed 2012-08-02 | 2.37M shares derived: sum of 3 quarters · filed 2013-02-26 | 2.67M shares derived: sum of 4 quarters · filed 2013-02-26 |
| 2012-03-31 | 200.00K shares 10-Q · filed 2012-04-30 | 467.46K shares derived: sum of 2 quarters · filed 2013-02-26 | 767.46K shares derived: sum of 3 quarters · filed 2013-02-26 | |
| 2011-12-31 | 267.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | 567.46K shares derived: sum of 2 quarters · filed 2013-02-26 | 3.87M shares 10-K · filed 2013-02-26 | |
| 2011-09-30 | 300.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | 3.60M shares 10-Q · filed 2011-10-31 | ||
| 2011-06-30 | 3.30M shares 10-Q · filed 2011-08-01 | |||
| 2010-12-31 | 3.55M shares 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |